📊 Note: Daily ratings and analytics are updated after market close and will be available by 7:00 PM IST.

Details

NameSymbolSector
GLAXOSMITHKLINE PHARMACEUTICALS LTD.GLAXOPharmaceuticals
Open
2305
High
2401.9
Low
2291.2
Close
2329.2
Volume
70124
Exchange
nse
Time
01-Apr-2026

Outlook

Score:  

5.5

Rating:  

FAIR

Candlestick Pattern

Candle pattern of Glaxosmithkline Pharmaceuticals is  
None
Estimated Stoploss of Glaxosmithkline Pharmaceuticals is ₹  
2291.2
Glaxosmithkline Pharmaceuticals has a  
Bullishℹ
 pattern. 
Formation of  
None
 candle pattern indicates the trend direction of Glaxosmithkline Pharmaceuticals is  
Unpredictableℹ
. 

Trend

Glaxosmithkline Pharmaceuticals is in  
Sideways trendℹ
. 
Price of Glaxosmithkline Pharmaceuticals is  
Downℹ
 by  

5.22

%. 
Target
Buy @ 

2230.96

Sell @ 

2680

Current @ 

2329.2

Volume

The trade volumes of Glaxosmithkline Pharmaceuticals have been  
Underperformingℹ
The volume trend for Glaxosmithkline Pharmaceuticals is  
Bearishℹ
, but the participants are  
Weak Sellersℹ
The trade volume of Glaxosmithkline Pharmaceuticals is  

Up

 by  

5.38

% 

Valuation

The current market price of Glaxosmithkline Pharmaceuticals is  
Undervaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 4108cr and total assets worth ₹ 4108cr, the balance sheet of Glaxosmithkline Pharmaceuticals is:  
Balancedℹ
. 
Cashflow
Glaxosmithkline Pharmaceuticals has  
Excellentℹ
 cash flow because there is  

Surplus

 of  

₹ 474cr

. It is  
Upℹ
 by  

1534.48

%. 

(*Mar 2025)

61.29% i.e. ₹ 1289cr earned in operatingℹ
2.14% i.e. ₹ 45cr spent in investingℹ
36.57% i.e. ₹ 769cr spent in financingℹ
0% in otherℹ
Glaxosmithkline Pharmaceuticals has  
Maintainedℹ
 cash flow because there is  

Surplus

 of  

₹ 29cr

. It is  
Upℹ
 by  

111.55

%. 

(*Mar 2024)

50.56% i.e. ₹ 582cr earned in operatingℹ
0.7% i.e. ₹ 8cr earned in investingℹ
48.74% i.e. ₹ 561cr spent in financingℹ
0% in otherℹ
Income
The income of Glaxosmithkline Pharmaceuticals is  

₹ 1013cr

 and  

Profit

 is :  

₹ 257cr

(*Sep 2025)

Glaxosmithkline Pharmaceuticals Profit is up by:  

25.37

% and Income is Up by:  

19.46

% 

(*Sep 2025)

The income of Glaxosmithkline Pharmaceuticals is  

₹ 848cr

 and  

Profit

 is :  

₹ 205cr

(*Jun 2025)

Glaxosmithkline Pharmaceuticals Profit is down by:  

21.76

% and Income is Down by:  

16.45

% 

(*Jun 2025)

The income of Glaxosmithkline Pharmaceuticals is  

₹ 1015cr

 and  

Profit

 is :  

₹ 262cr

(*Mar 2025)

Glaxosmithkline Pharmaceuticals Profit is up by:  

14.41

% and Income is Up by:  

3.15

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.